Cite
MLA Citation
Kerstin Kapp et al.. “Beneficial modulation of the tumor microenvironment and generation of anti-tumor responses by TLR9 agonist lefitolimod alone and in combination with checkpoint inhibitors.” Oncoimmunology, vol. 8, 2019, p. . http://access.bl.uk/ark:/81055/vdc_100099954549.0x000020